Surgery Partners Inc. (NASDAQ:SGRY) shares traded up 4.8% during mid-day trading on Monday . The stock traded as high as $20.06 and last traded at $20.04, with a volume of 231,900 shares. The stock had previously closed at $19.13.

Several research analysts recently issued reports on the stock. Jefferies Group reissued a “buy” rating and issued a $27.00 price target on shares of Surgery Partners in a research report on Wednesday, August 10th. Zacks Investment Research lowered shares of Surgery Partners from a “hold” rating to a “sell” rating in a research report on Wednesday, July 13th. KeyCorp assumed coverage on shares of Surgery Partners in a research report on Thursday, June 9th. They issued an “overweight” rating and a $21.00 price target for the company. Finally, Barclays PLC started coverage on shares of Surgery Partners in a research report on Wednesday, July 13th. They issued an “equal weight” rating and a $20.00 price target for the company. Four analysts have rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average target price of $22.44.

The company’s 50 day moving average is $18.04 and its 200-day moving average is $15.67. The company has a market cap of $972.54 million and a price-to-earnings ratio of 108.32.

Surgery Partners (NASDAQ:SGRY) last announced its earnings results on Tuesday, August 9th. The company reported $0.16 EPS for the quarter, topping the consensus estimate of $0.14 by $0.02. The company had revenue of $289.70 million for the quarter, compared to the consensus estimate of $275.99 million. The firm’s revenue for the quarter was up 24.4% on a year-over-year basis. Equities analysts anticipate that Surgery Partners Inc. will post $0.64 EPS for the current fiscal year.

In related news, VP Jennifer Baldock sold 2,500 shares of Surgery Partners stock in a transaction dated Monday, August 29th. The shares were sold at an average price of $19.20, for a total transaction of $48,000.00. Following the completion of the sale, the vice president now owns 66,983 shares of the company’s stock, valued at approximately $1,286,073.60. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Surgery Partners, Inc is a healthcare services company. The Company operates in three lines of business across the United States: Surgical Facility Services, Ancillary Services and Optical Services. The Company’s Surgical Facility Services segment consists of the operation of ambulatory surgery centers (ASCs) and surgical hospitals, which include its anesthesia services.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.